TABLE 3.
Clinical data and outcome associated with nonsignificant (NIL) and significant (SIL) increases in DGGR‐lipase activities during hospitalization in 345 critically ill dogs
| Variable | All dogs | NIL group | SIL group | P value |
|---|---|---|---|---|
| Number of dogs | 345 | 267 | 78 | |
| Admission DGGR‐lipase, U/L | ||||
| Range | 7‐15 616 | 7‐15 616 | 18‐4746 | |
| Median (IQR) | 95 (43‐263) | 76 (39‐262) | 139 (71‐281) | |
| Repeat DGGR‐lipase, U/L | ||||
| Range | 8‐20 700 | 8‐13 700 | 433‐20 700 | |
| Median (IQR) | 143 (56‐895) | 94 (45‐207) | 1656 (962‐3732) | |
| Clinical diagnosis of acute pancreatitis | 53 (15%) | 40 (15%) | 13 (17%) | <.001 |
| Events between lipase measurements | ||||
| Anesthesia | 37 (11%) | 31 (12%) | 6 (8%) | .326 |
| Abdominal surgery | 56 (16%) | 41 (15%) | 15 (19%) | .415 |
| Hemodialysis | 21 (6%) | 1 (0%) | 20 (26%) | <.001 |
| Duration of hospitalization, median (IQR), days | 7 (5‐11) | 7 (5‐9) | 10 (7‐14) | <.001 |
| Mortality | 63 (18%) | 41 (15%) | 22 (28%) | .01 |
Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; CRP, C‐reactive protein; gGT, gamma glutamyl transferase; GLDH, glutamate dehydrogenase; IQR, interquartile range.